Otwarty dostęp

Is Obesity Significantly Connected with Urogenital Disorders? – Systematic Review


Zacytuj

1. Włodarczyk M, Nowicka G. Obesity, DNA Damage, and Development of Obesity-Related Diseases. Int J Mol Sci 2019 Mar 6; 20(5): 1146. https://doi:10.3390/ijms20051146. PMID: 30845725; PMCID: PMC6429223.Search in Google Scholar

2. Żukiewicz-Sobczak W, Wróblewska P, Zwoliński J, Chmielewska-Badora J, Adamczuk P, Krasowska E, Zagórski J, Oniszczuk A, Piątek J, Silny W. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium. Annals of Agricultural and Environmental Medicine 2014; 21(3): 590–594.Search in Google Scholar

3. Żukiewicz-Sobczak W, Wróblewska P, Zwoliński J, Chmielewska-Badora J, Adamczuk P, Krasowska E, Zagórski J, Oniszczuk A, Piątek J, Silny W. Obesity and poverty paradox in developed countries. Ann Agric Environ Med 2014; 21(3): 590–594. https://doi:10.5604/12321966.1120608. PMID: 25292135.Search in Google Scholar

4. Oude Luttikhuis H, Baur L, Jansen H, Shrewsbury VA, O’Malley C, Stolk RP, Summerbell CD. WITHDRAWN: Interventions for treating obesity in children. Cochrane Database Syst Rev 2019; 3(3): CD001872. https://doi:10.1002/14651858.CD001872.pub3.Search in Google Scholar

5. Tremmel M, Gerdtham U-G, Nilsson PM, Saha S. Economic Burden of Obesity: A Systematic Literature Review. Int J Environ Res Public Health 2017; 14: 435.Search in Google Scholar

6. Goldsammler M, Merhi Z, Buyuk E. Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis. Reprod Biol Endocrinol 2018; 16(1): 45.Search in Google Scholar

7. Vurbic D, Harder VS, Redner RR, Lopez AA, Phillips JK, Higgins ST. Co-occurring obesity and smoking among U.S. women of reproductive age: Associations with educational attainment and health biomarkers and outcomes. Prev Med 2015; 80: 60–66. https://doi:10.1016/j.ypmed.2015.05.020.Search in Google Scholar

8. Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab 2020 Aug 1; 105(8): e2695–709. https://doi:10.1210/clinem/dgaa285. PMID: 32442310; PMCID: PMC7457958. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology 2018.Search in Google Scholar

9. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000 Apr; 21(2): 200–214. https://doi:10.1210/edrv.21.2.0394. PMID: 10782364.Search in Google Scholar

10. Michalakis K, Mintziori G, Kaprara A, Tarlatzis BC, Goulis DG. The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism 2013; 62(4): 457–478.Search in Google Scholar

11. Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophysial responses to continuous and intermittent delivery of hypothalamic gona-dotropin-releasing hormone. Science 1978 Nov 10; 202(4368): 631–633. https://doi:10.1126/science.100883. PMID: 100883.Search in Google Scholar

12. Adashi EY. Endocrinology of the ovary. Hum Reprod 1994 May; 9(5): 815–827. https://doi:10.1093/oxfordjournals.humrep.a138602. PMID: 7929728.Search in Google Scholar

13. Evans NP, Dahl GE, Mauger DT, Padmanabhan V, Thrun LA, Karsch FJ. Does estradiol induce the preovulatory gonadotropin-releasing hormone (GnRH) surge in the ewe by inducing a progressive change in the mode of operation of the GnRH neurosecretory system. Endocrinology 1995 Dec; 136(12): 5511–5519. https://doi:10.1210/endo.136.12.7588302.Search in Google Scholar

14. Counts DR, Pescovitz OH, Barnes KM, Hench KD, Chrousos GP, Sherins RJ, Comite F, Loriaux DL, Cutler GB Jr. Dissociation of adrenarche and gonadarche in precocious puberty and in isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1987 Jun; 64(6): 1174–1178. https://doi:10.1210/jcem-64-6-1174. PMID: 3571422.Search in Google Scholar

15. Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol 2018 Mar 9; 16(1): 22. https://doi:10.1186/s12958-018-0336-z. PMID: 29523133; PMCID: PMC5845358.Search in Google Scholar

16. Jain A, Polotsky AJ, Rochester D, Berga SL, Loucks T, Zeitlian G, Gibbs K, Polotsky HN, Feng S, Isaac B, Santoro N. Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab 2007 Jul; 92(7): 2468–2473. https://doi:10.1210/jc.2006-2274. Epub 2007 Apr 17. PMID: 17440019.Search in Google Scholar

17. Bozkurt L, Göbl CS, Rami-Merhar B, Winhofer Y, Baumgartner-Parzer S, Schober E, Kautzky-Willer A. The Cross-Link between Adipokines, Insulin Resistance and Obesity in Offspring of Diabetic Pregnancies. Horm Res Paediatr 2016; 86: 300–308. https://doi:10.1159/000448076.Search in Google Scholar

18. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996 Feb 1; 334(5): 292–295. https://doi:10.1056/NEJM199602013340503. PMID: 8532024.Search in Google Scholar

19. Frisch RE, Revelle R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science 1970 Jul 24; 169(3943): 397–399. https://doi:10.1126/science.169.3943.397. PMID: 5450378.Search in Google Scholar

20. Gosman GG, Katcher HI, Legro RS. Obesity and the role of gut and adipose hormones in female reproduction. Hum Reprod Update 2006 Sep–Oct; 12(5): 585–601. https://doi:10.1093/humupd/dml024. Epub 2006 Jun 14. PMID: 16775192.Search in Google Scholar

21. Egan OK, Inglis MA, Anderson GM. Leptin Signaling in AgRP Neurons Modulates Puberty Onset and Adult Fertility in Mice. J Neurosci 2017 Apr 5; 37(14): 3875–3886. https://doi:10.1523/JNEUROSCI.3138-16.2017. Epub 2017 Mar 8. PMID: 28275162; PMCID: PMC6596709.Search in Google Scholar

22. Zuure WA, Roberts AL, Quennell JH, Anderson GM. Leptin signaling in GABA neurons, but not glutamate neurons, is required for reproductive function. J Neurosci 2013; 33(45): 17874–17883. https://doi:10.1523/JNEUROSCI.2278-13.2013.Search in Google Scholar

23. Tena-Sempere M. Roles of ghrelin and leptin in the control of reproductive function. Neuroendocrinology 2007; 86(3): 229–241. https://doi:10.1159/000108410. Epub 2007 Sep 12. PMID: 17851226.Search in Google Scholar

24. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001 Feb; 120(2): 337–345. https://doi:10.1053/gast.2001.22158. PMID: 11159873.Search in Google Scholar

25. Nicolas R. Vulliémoz, Ennian Xiao, Linna Xia-Zhang, Marc Germond, Jean Rivier, Michel Ferin. Decrease in Luteinizing Hormone Pulse Frequency during a Five-Hour Peripheral Ghrelin Infusion in the Ovariectomized Rhesus Monkey. The Journal of Clinical Endocrinology & Metabolism 2004 1 Nov; 89(11): 5718–5723.Search in Google Scholar

26. Broglio F, Benso A, Castiglioni C, Gottero C, Prodam F, Destefanis S, Gauna C, van der Lely AJ, Deghenghi R, Bo M, Arvat E, Ghigo E. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 2003; 88(4): 1537–1542.Search in Google Scholar

27. Whatmore AJ, Hall CM, Jones J, Westwood M, Clayton PE. Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol (Oxf) 2003 Nov; 59(5): 649–654. https://doi:10.1046/j.1365--2265.2003.01903.x. PMID: 14616891.Search in Google Scholar

28. Cansell C, Denis RG, Joly-Amado A, Castel J, Luquet S. Arcuate AgRP neurons and the regulation of energy balance. Front Endocrinol (Lausanne) 2012; 3: 169. https://doi:10.3389/fendo.2012.00169.Search in Google Scholar

29. Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, Herzog H, Zukowska Z. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007; 13(7): 803–811.Search in Google Scholar

30. Sirotkin AV, Kardošová D, Alwasel SH, Harrath AH. Neuropeptide Y directly affects ovarian cell proliferation and apoptosis. Reprod Biol 2015 Dec; 15(4): 257–260. https://doi:10.1016/j.repbio.2015.07.004. Epub 2015 Aug 4. PMID: 26679167.Search in Google Scholar

31. Lee B, Shao J. Adiponectin and energy homeostasis. Rev Endocr Metab Disord 2014 Jun; 15(2): 149–156. https://doi:10.1007/s11154-013-9283-3. PMID: 24170312; PMCID: PMC4006341.Search in Google Scholar

32. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007 Jul; 6(1): 55–68. https://doi:10.1016/j.cmet.2007.06.003. PMID: 17618856.Search in Google Scholar

33. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002 Jul; 8(7): 731–717.Search in Google Scholar

34. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006 Jul; 116(7): 1784–1792. https://doi:10.1172/JCI29126. PMID: 16823476; PMCID: PMC1483172.Search in Google Scholar

35. Thaler JP, Schwartz MW. Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 2010 Sep; 151(9): 4109–4115. https://doi:10.1210/en.2010-0336. Epub 2010 Jun 23. PMID: 20573720; PMCID: PMC2940486.Search in Google Scholar

36. Chabrolle C, Tosca L, Dupont J. Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction 2007 Apr; 133(4): 719–731.Search in Google Scholar

37. Lundon JR. Insulin-some current concepts. Can Fam Physician 1970 Jul; 16(7): 58–61. PMID: 20468537; PMCID: PMC2281770.Search in Google Scholar

38. Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K, Simon D; Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the telecom study. J Clin Endocrinol Metab 1993 Feb; 76(2): 283–287.Search in Google Scholar

39. Brothers KJ, Wu S, DiVall SA, Messmer MR, Kahn CR, Miller RS, Radovick S, Wondisford FE, Wolfe A. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor. Cell Metab 2010 Sep 8; 12(3): 295–305. https://doi:10.1016/j.cmet.2010.06.010. PMID: 20816095; PMCID: PMC2935812.Search in Google Scholar

40. Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996 Jan; 81(1): 302–309.Search in Google Scholar

41. Ou XH, Li S, Wang ZB, Li M, Quan S, Xing F, Guo L, Chao SB, Chen Z, Liang XW, Hou Y, Schatten H, Sun QY. Maternal insulin resistance causes oxidative stress and mitochondrial dysfunction in mouse oocytes. Hum Reprod 2012 Jul.Search in Google Scholar

42. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999 Aug; 20(4): 535–582. https://doi:10.1210/edrv.20.4.0374. PMID: 10453357.Search in Google Scholar

43. Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 2011; 17(1): 17–33. https://doi:10.1093/humupd/dmq032.Search in Google Scholar

44. Jungheim ES, Travieso JL, Hopeman MM. Weighing the impact of obesity on female reproductive function and fertility. Nutr Rev 2013 Oct; 71 Suppl 1(01): S3–8. https://doi:10.1111/nure.12056.Search in Google Scholar

45. Sørensen TI, Virtue S, Vidal-Puig A. Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects? Biochim Biophys Acta 2010 Mar; 1801(3): 400–404. https://doi:10.1016/j.bbalip.2009.12.011.Search in Google Scholar

46. Chambers TJ, Richard RA. The impact of obesity on male fertility. Hormones (Athens) 2015 Oct–Dec; 14(4): 563–568. https://doi:10.14310/horm.2002.1621. PMID: 26732149.Search in Google Scholar

47. Sundaram R, Mumford SL, Buck Louis GM. Couples’ body composition and time-to-pregnancy. Hum Reprod 2017 Mar 1; 32(3): 662–668. https://doi:10.1093/humrep/dex001. PMID: 28158570; PMCID: PMC5400044.Search in Google Scholar

48. Campbell JM, Lane M, Owens JA, Bakos HW. Paternal obesity negatively affects male fertility and assisted reproduction outcomes: a systematic review and meta-analysis. Reprod Biomed Online 2015 Nov; 31(5): 593–604. https://doi:10.1016/j.rbmo.2015.07.012. Epub 2015 Aug 10. PMID: 26380863.Search in Google Scholar

49. Eisenberg ML, Kim S, Chen Z, Sundaram R, Schisterman EF, Buck Louis GM. The relationship between male BMI and waist circumference on semen quality: data from the LIFE study. Hum Reprod 2014 Feb; 29(2): 193–200. https://doi:10.1093/humrep/det428.Search in Google Scholar

50. Tsao CW, Liu CY, Chou YC, Cha TL, Chen SC, Hsu CY. Exploration of the association between obesity and semen quality in a 7630 male population. PLoS One 2015 Mar 30; 10(3): e0119458. https://doi:10.1371/journal.pone.0119458. PMID: 25822490; PMCID: PMC4379020.Search in Google Scholar

51. Mushtaq R, Pundir J, Achilli C, Naji O, Khalaf Y, El-Toukhy T. Effect of male body mass index on assisted reproduction treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online 2018 Apr 36(4): 459–471. https://doi:10.1016/j.rbmo.2018.01.002.Search in Google Scholar

52. Katib A. Mechanisms linking obesity to male infertility. Cent European J Urol 2015; 68(1): 79–85. https://doi:10.5173/ceju.2015.01.435. Epub 2015 Mar 13. PMID: 25914843; PMCID: PMC4408383.Search in Google Scholar

53. Liu Y, Ding Z. Obesity, a serious etiologic factor for male subfertility in modern society. Reproduction 2017 Oct; 154(4): R123–R131. https://doi:10.1530/REP-17-0161.Search in Google Scholar

54. Best D, Avenell A, Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update 2017 Nov 1; 23(6): 681–705. https://doi:10.1093/humupd/dmx027.Search in Google Scholar

55. McPherson NO, Lane M. Male obesity and subfertility, is it really about increased adiposity? Asian J Androl 2015; 17(3): 450–458. https://doi:10.4103/1008-682X.148076.Search in Google Scholar

56. Charles D. Scales Jr. Prevalence of Kidney Stones in the United States. European Urology 2012; 62(1): 160–165.Search in Google Scholar

57. Shavit L, Ferraro PM, Johri N, Robertson W, Walsh SB, Moochhala S, Unwin R. Effect of being overweight on urinary metabolic risk factors for kidney stone formation. Nephrol Dial Transplant 2015 Apr; 30(4): 607–613. https://doi:10.1093/ndt/gfu350. Epub 2014 Oct 31. PMID: 25362001.Search in Google Scholar

58. Brynarski P. Cukrzyca i otyłość jako czynniki ryzyka wystąpienia kamicy nerkowej. www.mp.pl [Internet]. Available from https://diabeto-logia.mp.pl/powiklania/inne/205979,cukrzyca-i-otylosc-jako-czynnikiryzyka-wystapienia-kamicy-nerkowej [cited 15.03.2019].Search in Google Scholar

59. Lamerton TJ, Torquati L, Brown WJ. Overweight and obesity as major, modifiable risk factors for urinary incontinence in young to mid-aged women: a systematic review and meta-analysis. Obes Rev 2018 Dec; 19(12): 1735–1745. https://doi:10.1111/obr.12756. Epub 2018 Sep 19. PMID: 30230164.Search in Google Scholar

60. Milsom I, Gyhagen M. The prevalence of urinary incontinence. Climacteric 2019 Jun; 22(3): 217–222. https://doi:10.1080/13697137.2018.1543263.Search in Google Scholar

61. Lugo T, Riggs J. Stress Incontinence [Updated 2020 Nov 20]. In: Stat-Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539769/.Search in Google Scholar

62. Wing RR, West DS, Grady D, Creasman JM, Richter HE, Myers D, Burgio KL, Franklin F, Gorin AA, Vittinghoff E, Macer J, Kusek JW, Subak LL. Program to Reduce Incontinence by Diet and Exercise Group. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol 2010 Sep; 184(3): 1005–1010. https://doi:10.1016/j.juro.2010.05.031. PMID: 20643425; PMCID: PMC3038435.Search in Google Scholar

63. Sun Y, Ge X, Li X, He J, Wei X, Du J, Sun J, Li X, Xun Z, Liu W, Zhang H, Wang ZY, Li YC. High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction. Cell Death Dis 2020 Oct 24; 11(10): 914. https://doi:10.1038/s41419-020-03122-4. PMID: 33099578; PMCID: PMC7585574.Search in Google Scholar

64. Ross WR, McGill JB. Epidemiology of obesity and chronic kidney disease. Adv Chronic Kidney Dis 2006 Oct; 13(4): 325–335. https://doi:10.1053/j.ackd.2006.07.012. PMID: 17045219.Search in Google Scholar

65. D’Agati, VD, Chagnac A, de Vries APJ, Levi M, Porrini E, Herman-Edelstein M, Praga M. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol 2016; 12(8): 453– 471. https://doi.org/10.1038/nrneph.2016.75.Search in Google Scholar

66. Shen WW, Chen HM, Chen H, Xu F, Li LS, Liu ZH. Obesity-related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol 2010 Aug; 5(8): 1401–1409. https://doi:10.2215/CJN.01370210. Epub 2010 May 24. PMID: 20498244; PMCID: PMC2924407.Search in Google Scholar

67. Semins MJ, Shore AD, Makary MA, Weiner J, Matlaga BR. The Impact of Obesity on Urinary Tract Infection Risk. Urology 2012 Feb; 79(2): 266–269.Search in Google Scholar

68. Hsu Po-Chang, Chen Shyi-Jou. Obesity and risk of urinary tract infection in young children presenting with fever. Medicine 2018 Dec; 97(49): e13006. https://doi:10.1097/MD.0000000000013006.Search in Google Scholar

69. Matthew E Falagas, Maria Kompoti. Obesity and infection. Lancet Infect Dis 2006; 6: 438–446.Search in Google Scholar

70. Liu Xuezhen, Qi Sun, Haifeng Hou, Kai Zhu, Qian Wang, Huamin Liu, Qianqian Zhang, Long Ji, Dong Li. The association between BMI and kidney cancer risk: An updated dose – response meta – analysis in accordance with PRISMA guideline. Medicine 2018 Nov; 97(44): e12860. https://doi:10.1097/MD.0000000000012860.Search in Google Scholar

71. Nam Ga Eun, Cho Kyung Hwan, Han Kyungdo, Kim Chul Min et al. Obesity, abdominal obesity and subsequent risk of kidney cancer: a cohort study of 23.3 million East Asians. Br J Cancer 2019; 121: 271–277. https://doi.org/10.1038/s41416-019-0500-z.Search in Google Scholar

72. Sanchez A. et al. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study. Lancet Oncol 2020 Feb; 21(2): 283–293. https://doi.org/10.1016/S1470-2045(19)30797-1.Search in Google Scholar

73. Holroyd-Leduc JM, Tannenbaum C, Thorpe KE et al: What type of urinary incontinence does this woman have? JAMA 2008; 299(12): 1446– 1456.Search in Google Scholar

74. Bender S, Borowski J, Borkowski T, Torz C, Radziszewski P. Nietrzymanie moczu. Medycyna po Dyplomie 2011(20); 6(183): 73–80.Search in Google Scholar

75. Drewa T, Juszczak K. Urologia. Ilustrowany podręcznik dla studentów i stażystów. Warszawa: PZWL; 2018.Search in Google Scholar

76. Kobashi KC, Albo ME, Dmochowski RR et al. Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline. J Urol 2017 Oct; 198(4): 875.Search in Google Scholar

77. Paulina Smektała, Paweł Bogdański. Nephroprotective role of body mass reduction in obesity. Forum Zaburzeń Metabolicznych 2011; 2(3): 198–204.Search in Google Scholar

78. Hall KD, Sacks G, Chandramohan D, Chow CC, Wang YC, Gortmaker SL, Swinburn BA. Quantification of the effect of energy imbalance on bodyweight. Lancet 2011 Aug 27; 378(9793): 826–837. https://doi:10.1016/S0140-6736(11)60812-X. PMID: 21872751; PMCID: PMC3880593.Search in Google Scholar

79. Nakamura T, Kuranuki S. Nutrition – Macronutrients. In: Vasan RS, Sawyer DB, eds. Encyclopedia of cardiovascular research and medicine. Elsevier; 2018.Search in Google Scholar

80. Agam B. Bansal, Yasir Al Khalili. Orlistat In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021 Jan.Search in Google Scholar

81. Gadde KM, Martin CK, Berthoud HR, Heymsfield SB. Obesity: Pathophysiology and Management. J Am Coll Cardiol 2018; 71(1): 69–84. https://doi:10.1016/j.jacc.2017.11.011.Search in Google Scholar

82. National Institute for Health and Care Excellence Technology appraisal guidance: Naltrexone – bupropion for managing overweight and obesity. Technology appraisal guidance [TA494]. NICE; 2014 [Internet]. Available from: https://www.nice.org.uk/guidance/ta494/resources/naltrexonebupropion-for-managing-overweight-and-obesity-pdf-82605086955205.Search in Google Scholar

83. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev 2014; 8(8): CD003641.Search in Google Scholar

84. Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond) 2019; 19(3): 205–212. https://doi:10.7861/clinmedicine.19-3-205.Search in Google Scholar

85. Chandrasekaran S, Neal-Perry G. Long-term consequences of obesity on female fertility and the health of the offspring. Curr Opin Obstet Gynecol 2017; 29(3): 180–187.Search in Google Scholar

86. Amiri M, Ramezani Tehrani F. Potential Adverse Effects of Female and Male Obesity on Fertility: A Narrative Review. Int J Endocrinol Metab 2020; 18(3): e101776. Published 2020 Sep 28. https://doi:10.5812/ijem.101776.Search in Google Scholar

87. Chambers TJ, Richard RA. The impact of obesity on male fertility. Hormones (Athens) 2015; 14(4): 563–568.Search in Google Scholar

88. Snyder S, Turner GA, Turner A. Obesity-related kidney disease. Prim Care 2014 Dec; 41(4): 875–893.Search in Google Scholar

89. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009; 4(10): 1565–1574. https://doi:10.2215/CJN.02250409. Epub 2009 Sep 17. PMID: 19808241; PMCID: PMC2758256.Search in Google Scholar

90. Saeed Z, Janda KM, Tucker BM, Dudley L, Cutter P, Friedman AN. Personal Attitudes Toward Weight in Overweight and Obese US Hemodialysis Patients. J Ren Nutr 2017 Sep; 27(5): 340–345. https://doi:10.1053/j.jrn.2017.03.004. Epub 2017 May 19. PMID: 28533101.Search in Google Scholar

91. Lanoye A, Grenga A, Leahey TM, LaRose JG. Motivation for weight loss and association with outcomes in a lifestyle intervention: comparing emerging adults to middle aged adults. Obes Sci Pract 2018; 5(1): 15–20. https://doi:10.1002/osp4.313.Search in Google Scholar